Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03184558
Title BGB324 in Combination With Pembrolizumab in Patients With TNBC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors BerGenBio ASA
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP


No variant requirements are available.